While our initial observations examined the behavior of proto-oncogene MYC across various stages of prostate cancer, we sought to examine the behavior of MYC in other cancer types, including melanoma, lung, ovarian, pancreatic, and breast. This evidence concerns the gene MYC and prostate carcinoma.